Vanderbilt-Ingram Cancer Center

Individuals who are outside the “normal” range of expression for the APC gene have an increased risk of colorectal cancer, according to a study published in the January issue of Gastroenterology. Mutations in the APC (adenomatous polyposis coli) gene – and variations in the expression of the gene’s two copies (allele-specific expression) — are associated [...]

In the 40 years since President Nixon “declared war” on cancer, much progress has been made. We are screening more, catching cancers sooner, using DNA information to tailor treatment to the individual. Still, cancer is responsible for one in four deaths in the United States.

A team of Vanderbilt-Ingram Cancer Center scientists, led by Daniel Liebler, Ph.D., professor of Biochemistry, Biomedical Informatics and Pharmacology, has been selected to participate in the Clinical Proteomic Tumor Analysis Consortium (CPTAC), a multi-center cancer research program created by the National Cancer Institute (NCI). Liebler will lead the Vanderbilt Proteome Characterization Center, one of five [...]

MyCancerGenome, the online medical decision support tool for cancer care developed by Vanderbilt physician-scientists, has been selected as a finalist for a health care technology award. The contest, “Using Public Data for Cancer Prevention and Control: From Innovation to Impact Developer Challenge,” is sponsored by the National Cancer Institute (NCI), Division of Cancer Control and [...]

As a veteran meteorologist for WKRN Channel 2 in Nashville, Davis Nolan is an expert at diagnosing weather patterns that can create violent winds and thunderous storms. But he had no hints about the potentially deadly storms that were brewing inside his own body until a routine visit to his primary care physician led to [...]

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named one of the winners of this year’s Susan G. Komen for the Cure Brinker Awards for Scientific Distinction. The Brinker Awards for Scientific Distinction were established in 1992 to recognize the efforts of [...]

William Pao, M.D., Ph.D., associate professor of Medicine and director of Personalized Cancer Medicine at Vanderbilt, has been named director of the Division of Hematology and Oncology in the Department of Medicine. “Dr. Pao has demonstrated tremendous leadership and creativity since arriving at Vanderbilt,” said Nancy Brown, M.D., chair and physician-in chief of the Department [...]

Lauren Hackett, MPA, has been named executive director for cancer research administration at Vanderbilt-Ingram Cancer Center. Hackett has 19 years of experience in research administration, most recently at New York University Cancer Institute, where she has served as executive director for administration since 2004. She held similar roles with the Yale School of Medicine and [...]

Vanderbilt-Ingram Cancer Center has opened a free-standing cancer clinic in Green Hills to give cancer patients more options for their oncology care. VICC Green Hills provides many of the same services available at the main VICC campus, including access to board-certified cancer physicians and specially trained oncology nurses and pharmacists. Patients can see an oncologist, [...]

News that the Food and Drug Administration had approved a new targeted drug for advanced melanoma was heralded as good news this week by physician-scientists at Vanderbilt-Ingram Cancer Center, which was involved in many of the studies that helped lead to the approval. “This is a bright day for many melanoma patients,” said Dr. Jeffrey [...]